One-Time cell infusion could free kidney patients from lifelong drug burden
Disease control
Recruiting now
This trial is testing whether a one-time infusion of specially grown immune cells can help prevent a patient's body from rejecting a new kidney. The goal is to see if this cell therapy allows patients to safely take fewer anti-rejection drugs long-term. Researchers will compare p…
Phase: PHASE2 • Sponsor: Singulera Therapeutics Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC